Bleached Shellac as an Alternative Polymeric Matrix for In Situ Microparticle

Pitsiree Praphanwittaya; Thawatchai Phaechamud

doi:10.4028/www.scientific.net/KEM.659.8

Paper Titles

Preface, Committees and Sponsors

In Vitro Resorbability of Three Different Processed Hydroxyapatite
p.3

Bleached Shellac as an Alternative Polymeric Matrix for In Situ Microparticle
p.8

Metrodidazole In Situ Forming Eudragit RS Gel Comprising Different Solvents
p.13

Physical and Mechanical Characterizations of Oxidized Regenerated Cellulose/Polycaprolactone Composite for Use as a Synthetic Dura Mater
p.19

Physical Properties of Xyloglucan/Bacterial Cellulose Composite Film Plasticized with Glycerol
p.24

Preparation and Characterization of Polymer Blends from Nang noi srisaket 1 Silk Fibroin, Gelatin and Chitosan Nanofiber Mats Using Formic Acid Solution
p.28

Sintered Titanium-Hydroxyapatite Composites as Artificial Bones
p.35

Synthesis and Characterization of Artificial Bone Material Using Calcium from a Natural Source
p.40

HomeKey Engineering MaterialsKey Engineering Materials Vol. 659Bleached Shellac as an Alternative Polymeric...

Bleached Shellac as an Alternative Polymeric Matrix for In Situ Microparticle

Abstract:

Bleached shellac (BS), a biodegradable natural resin purified from insect lac, has been used in a varity of controlled drug delivery systems. Nevertheless, there were negligible researches explored the potential of it as in injectable in situ microparticles (ISM) applications. The goal of this study was to utilize BS to form ISM (shellac-solution dispersed into an external olive oil phase, as o/o emulsion) prepared by two-syringe technique. Addition of glyceryl monostearate (GMS) as stabilizer obviously decreased the emulsion droplet size. ISM emulsion comprising 5% w/w GMS in external phase could form into droplets and precipitate in form of microparticles after exposure to phosphate buffer. 2-Pyrrolidone was the most appropriate solvent to form massive microparticles with regular shape especially at ratio of 7:3 external:internal phases. ISM transformation was occurred after exposure to phosphate buffer and tended to reduce the droplet size when ratio of external phase was higher than 50%. Incorporation of doxycycline hyclate did not influence the amount and size of ISM. Therefore shellac exhibited as an alternative polymer matrix for ISM which higher amount of GMS could reduce the size of emulsion droplet and volume phase ratio seriously influenced on emulsion size and ISM formation.

You might also be interested in these eBooks

View Preview

Info:

Periodical:

Key Engineering Materials (Volume 659)

Pages:

8-12

DOI:

https://doi.org/10.4028/www.scientific.net/KEM.659.8

Citation:

Cite this paper

Online since:

August 2015

Authors:

Pitsiree Praphanwittaya, Thawatchai Phaechamud*

Keywords:

In Situ Microparticles, Non-Aqueous

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

* - Corresponding Author

References

[1] A. Patel, P. Heussen, J. Hazekamp, K.P. Velikov, Soft matter 7 (2011) 8549–8555.

Google Scholar

[2] X. Luan, R. Bodmeier. Influence of the poly (lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. J. Control. Rel. 110 (2006) 266–272.

DOI: 10.1016/j.jconrel.2005.10.005

Google Scholar

[3] N. Pearnchob, R. Bodmeier. Dry polymer powder coating and comparison with conventional liquid-based coatings for eudragit RS, ethylcellulose and shellac. Eur. J. Pharm. Biopharm. 56 (2003) 363-369.

DOI: 10.1016/s0939-6411(03)00121-8

Google Scholar

[4] V. Ravi, S. Kumar. Influence of natural polymer coating on novel colon targeting drug delivery system. J. Mater. Sci. Mater. Med. 19 (2008) 2131-2136.

DOI: 10.1007/s10856-007-3155-x

Google Scholar

[5] A. Roda, P. Simoni, M. Magliulo, P. Nanni, M. Baraldini, G. Roda, E. Roda. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. World J. Gastroenterol. 13 (2007) 1079-1084.

DOI: 10.3748/wjg.v13.i7.1079

Google Scholar

[6] A. Khaled, G. Csoka, S. Odri, A. Auner, I. Klebovich, S. Marton. New application possibilities of shellac. Eur. J. Pharm. Sci. 25 (2005) 130-S132.

Google Scholar

[7] X. Luan, R. Bodmeier. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters. Eur. J. Pharm. Sci. 27 (2006) 143–149.

DOI: 10.1016/j.ejps.2005.09.002

Google Scholar

[8] H. Kranz, G.A. Brazeau, et al. Myotoxicity studies of injectable biodegradable in situ forming drug delivery systems. Int. J. Pharm. 212 (2001) 11–18.

DOI: 10.1016/s0378-5173(00)00568-8

Google Scholar

[9] M. Voigt, M. Koerber, R. Bodmeier. Improve physical stability and injectability of non-aqueous in situ PLGA microparticle forming emulsion. Int. J. Pharm. 434 (2012) 251-256.

DOI: 10.1016/j.ijpharm.2012.05.029

Google Scholar

[10] C. H. Chen, E. M. Terentjev. Aging and metastability of monoglycerides in hydrophobic solutions. Langmuir. 25(12) (2009) 6717-6724.

DOI: 10.1021/la9002065

Google Scholar

[11] S. M. Hodge, D. Rousseau. Continuous-phase fat crystals strongly influence water-in-oil emulsion stability. J. Am. Oil Chem. Soc. 82(3) (2005) 159-164.

DOI: 10.1007/s11746-005-5166-4

Google Scholar

[12] Y. Farag. Characterization of different shellac types and development of shellac-coated dosage forms. Department of Chemistry, Pharmacy, University of Hamburg, (2010).

Google Scholar

[13] A. F. M. Barton. Solubility parameters. Chem. Rev. 75, (1975) 731-753.

Google Scholar

[14] S. Tcholakova, N. D. Denkov, et al. Coalescence in β-lactoglobulin-stabilized emulsions: effects of protein adsorption and drop size. Langmuir. 18(23) (2002) 8960-8971.

DOI: 10.1021/la0258188

Google Scholar